News

As the curtain falls on 2023, we look back on a year steeped in significance for the EMCDDA. While we commemorated 30 years since the agency's creation, we also prepared for a...

The EMCDDA and the Correlation – European Harm Reduction Network ( C-EHRN) have published today the latest overview on drug consumption rooms (DCRs) in Europe. The purpose of the report is to...

Registration opens today for the next European Conference on Addictive Behaviours and Dependencies (Lisbon Addictions 2024) taking place in Lisbon from 23–25 October 2024. The multidisciplinary event will showcase cutting-edge scientific research...

Health and social responses for migrants who use drugs are explored in a new EMCDDA miniguide launched today to mark International Migrants Day. The resource is one of a series of miniguides...

On the eve of World AIDS Day, the EMCDDA showcases the latest data on HIV among people who inject drugs (PWID) and explores how countries are performing on global health sector objectives...

EMCDDA Director Alexis Goosdeel is at the European Parliament today where he will be presenting the European Drug Report 2023: Trends and Developments (EDR 2023) to members of the Committee for Civil...

Health risk communication strategies for drug checking services in Europe is the focus of a new EMCDDA manual out today. The resource provides staff working in these services with practical guidance on...

Cannabis products are becoming increasingly potent and diverse, while collaboration between criminal groups is creating new security risks in Europe. These are among the conclusions of a new analysis — EU Drug...

This week, the EMCDDA has launched a call to scientists interested in applying to be on a list of experts who may assist the European Union Drugs Agency (EUDA) in the risk...

Today, the EMCDDA has launched a call for expression of interest in membership of the Scientific Committee of the European Union Drugs Agency (EUDA). The EUDA, which will replace the EMCDDA, will...

Today, the EMCDDA is kicking off the latest culturally adapted European Prevention Curriculum (EUPC) basic training course in Portuguese in Brazil. Under its partnership with the COPOLAD III programme, the EMCDDA has...

Six interventions, one aim: to prevent and control infections among people who inject drugs. In new public health guidance released today, the European Centre for Disease Prevention and Control ( ECDC) and...

Representatives of the European Parliament are visiting the EMCDDA this week to discuss how the agency will adapt to its new mandate in 2024. New legislation published on 30 June grants the...

We are delighted to announce that our colleague Laurent Laniel has been presented with the medal of excellence of the Maritime Analysis and Operations Centre-Narcotics (MAOC (N)). He received the award for...

This week in Montevideo, the EMCDDA is co-organising with the Uruguayan Junta Nacional de Drogas, a technical dialogue on cannabis policies. The event is one of a range of activities organised by...

The EMCDDA and the University Institute of Lisbon (ISCTE-IUL) are delighted to announce the availability of bursaries for the 2024 European Drugs Winter and Summer Schools. The bursaries are being offered via...

This week, EMCDDA Director Alexis Goosdeel is making an official visit to Peru in the framework of the agency's Working Arrangement with the Peruvian national drug observatory, DEVIDA ( 1). This is...

Amphetamine is the most common synthetic stimulant available in Europe, constituting a large and stable market worth a minimum of EUR 1.1 billion annually. In a new analysis released today — EU...

Better access to drug-related services for asylum seekers and empowering reception centre workers through training in drug use response are among the priorities highlighted in a new report out today: Professionals working...

The EMCDDA and the University Institute of Lisbon (ISCTE-IUL) are delighted to open registration today for two upcoming joint events in 2024: the European Drugs Winter School (EDWS) and the European Drugs...